Met Life Investment Management, LLC Vista Gen Therapeutics, Inc. Transaction History

Met Life Investment Management, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jun 20, 2023	BUY	$0.88 - $1.73 $117,296 - $230,593	133,291 New	133,291 $117,000
Q1 2022 May 10, 2024	BUY	$1.14 - $2.09 $151,951 - $278,578	133,291 New	133,291 $165,000
Q1 2022 Jun 20, 2023	BUY	$1.14 - $2.09 $151,951 - $278,578	133,291 New	133,291 $165,000
Q1 2022 Mar 22, 2023	BUY	$1.14 - $2.09 $56,081 - $102,815	49,194 Added 58.5%	133,291 $165,000
Q1 2022 May 12, 2022	BUY	$1.14 - $2.09 $56,081 - $102,815	49,194 Added 58.5%	133,291 $165,000

Q4 2021 Jun 21, 2023	BUY	$1.67 - $2.76 $140,441 - $232,107	84,097 New	84,097 $163,000
Q3 2021 Jun 21, 2023	BUY	$2.62 - $3.45 $220,334 - $290,134	84,097 New	84,097 $230,000
Q2 2021 May 17, 2024	BUY	$1.96 - $3.15 $164,830 - $264,905	84,097 New	84,097 $264,000
Q2 2021 Jun 21, 2023	BUY	$1.96 - $3.15 $164,830 - $264,905	84,097 New	84,097 $264,000
Q2 2021 Mar 22, 2023	BUY	$1.96 - $3.15 $164,830 - $264,905	84,097 New	84,097 $264,000
Q2 2021 Aug 16, 2021	BUY	$1.96 - $3.15 $164,830 - $264,905	84,097 New	84,097 $265,000

2.7M

Ticker VTGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 206,836,000
Market Cap $730M
Description
VistaGen Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing various medicines with the potential to care for anxiety, depression, and other disorders of the central nervous system (CNS). The company's CNS pipeline includes PH94B, a rapid-onset neuroactive nasal spray, which is in Phase III d...

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Met Life Investment Management, LLC with notifications on news.